378 related articles for article (PubMed ID: 10778988)
41. An in vitro investigation of the induction of apoptosis and modulation of cell cycle events in human cancer cells by bisphenanthroline-coumarin-6,7-dioxacetatocopper(II) complex.
Thati B; Noble A; Creaven BS; Walsh M; Kavanagh K; Egan DA
Chem Biol Interact; 2007 Jun; 168(2):143-58. PubMed ID: 17512508
[TBL] [Abstract][Full Text] [Related]
42. Toward the development of metal-based synthetic nucleases: DNA binding and oxidative DNA cleavage of a mixed copper(II) complex with N-(9H-purin-6-yl)benzenesulfonamide and 1,10-phenantroline. Antitumor activity in human Caco-2 cells and Jurkat T lymphocytes. Evaluation of p53 and Bcl-2 proteins in the apoptotic mechanism.
García-Giménez JL; González-Alvarez M; Liu-González M; Macías B; Borrás J; Alzuet G
J Inorg Biochem; 2009 Jun; 103(6):923-34. PubMed ID: 19428113
[TBL] [Abstract][Full Text] [Related]
43. Synthesis, characterization and biological activity of oxovanadium (IV) complexes with cyclic polyalcohols.
Etcheverry SB; Barrio DA; Zinczuk J; Williams PA; Baran EJ
J Inorg Biochem; 2005 Dec; 99(12):2322-7. PubMed ID: 16219358
[TBL] [Abstract][Full Text] [Related]
44. Investigation of the role of Bax, p21/Waf1 and p53 as determinants of cellular responses in HCT116 colorectal cancer cells exposed to the novel cytotoxic ruthenium(II) organometallic agent, RM175.
Hayward RL; Schornagel QC; Tente R; Macpherson JS; Aird RE; Guichard S; Habtemariam A; Sadler P; Jodrell DI
Cancer Chemother Pharmacol; 2005 Jun; 55(6):577-83. PubMed ID: 15726367
[TBL] [Abstract][Full Text] [Related]
45. Synthesis and crystal structure of two new dinuclear cobalt(II) complexes interaction with HeLa cells.
Gao EJ; Gao XN; Guan F; Zhu MC; Liu L; Zhang M; Zhang YX; Wang Y; Wen Z; Zhang Y; Zhang Y; Liang Q
Eur J Med Chem; 2011 Jan; 46(1):160-7. PubMed ID: 21093965
[TBL] [Abstract][Full Text] [Related]
46. Synthesis, characterization and biological properties of cobalt(II) complexes of 1,10-phenanthroline and maltol.
Chin LF; Kong SM; Seng HL; Khoo KS; Vikneswaran R; Teoh SG; Ahmad M; Khoo SB; Maah MJ; Ng CH
J Inorg Biochem; 2011 Mar; 105(3):339-47. PubMed ID: 21421121
[TBL] [Abstract][Full Text] [Related]
47. Structural properties and dissociative fluxional motion of 2,9-dimethyl-1,10-phenanthroline in platinum(II) complexes.
Romeo R; Carnabuci S; Plutino MR; Romeo A; Rizzato S; Albinati A
Inorg Chem; 2005 Mar; 44(5):1248-62. PubMed ID: 15732965
[TBL] [Abstract][Full Text] [Related]
48. Studies of the mechanism of action of platinum(II) complexes with potent cytotoxicity in human cancer cells.
Krause-Heuer AM; Grünert R; Kühne S; Buczkowska M; Wheate NJ; Le Pevelen DD; Boag LR; Fisher DM; Kasparkova J; Malina J; Bednarski PJ; Brabec V; Aldrich-Wright JR
J Med Chem; 2009 Sep; 52(17):5474-84. PubMed ID: 19658404
[TBL] [Abstract][Full Text] [Related]
49. Large-bite bis(phosphite) ligand containing mesocyclic thioether moieties: synthesis, reactivity, group 11 (Cu(I), Au(I)) metal complexes and anticancer activity studies on a human cervical cancer (HeLa) cell line.
Suresh D; Balakrishna MS; Rathinasamy K; Panda D; Mague JT
Dalton Trans; 2008 May; (17):2285-92. PubMed ID: 18414753
[TBL] [Abstract][Full Text] [Related]
50. Spectroscopic and potentiometric characterization of oxovanadium(IV) complexes formed by 3-hydroxy-4-pyridinones. Rationalization of the influence of basicity and electronic structure of the ligand on the properties of V(IV)O species in aqueous solution.
Rangel M; Leite A; João Amorim M; Garribba E; Micera G; Lodyga-Chruscinska E
Inorg Chem; 2006 Oct; 45(20):8086-97. PubMed ID: 16999406
[TBL] [Abstract][Full Text] [Related]
51. DNA binding, antitumor activities, and hydroxyl radical scavenging properties of novel oxovanadium (IV) complexes with substituted isoniazid.
Liao X; Lu J; Ying P; Zhao P; Bai Y; Li W; Liu M
J Biol Inorg Chem; 2013 Dec; 18(8):975-84. PubMed ID: 24077688
[TBL] [Abstract][Full Text] [Related]
52. Novel copper(II) complex of N-propyl-norfloxacin and 1,10-phenanthroline with enhanced antileukemic and DNA nuclease activities.
Katsarou ME; Efthimiadou EK; Psomas G; Karaliota A; Vourloumis D
J Med Chem; 2008 Feb; 51(3):470-8. PubMed ID: 18205294
[TBL] [Abstract][Full Text] [Related]
53. DNA binding and biological activity of some platinum(II) intercalating compounds containing methyl-substituted 1,10-phenanthrolines.
Brodie CR; Collins JG; Aldrich-Wright JR
Dalton Trans; 2004 Apr; (8):1145-52. PubMed ID: 15252653
[TBL] [Abstract][Full Text] [Related]
54. Novel titanocene anti-cancer drugs and their effect on apoptosis and the apoptotic pathway in prostate cancer cells.
O'Connor K; Gill C; Tacke M; Rehmann FJ; Strohfeldt K; Sweeney N; Fitzpatrick JM; Watson RW
Apoptosis; 2006 Jul; 11(7):1205-14. PubMed ID: 16699961
[TBL] [Abstract][Full Text] [Related]
55. The effect of ancillary ligand chirality and phenanthroline functional group substitution on the cytotoxicity of platinum(II)-based metallointercalators.
Kemp S; Wheate NJ; Buck DP; Nikac M; Collins JG; Aldrich-Wright JR
J Inorg Biochem; 2007 Jul; 101(7):1049-58. PubMed ID: 17544512
[TBL] [Abstract][Full Text] [Related]
56. Structural studies and cytotoxic activity of N(4)-phenyl-2-benzoylpyridine thiosemicarbazone Sn(IV) complexes.
Perez-Rebolledo A; Ayala JD; de Lima GM; Marchini N; Bombieri G; Zani CL; Souza-Fagundes EM; Beraldo H
Eur J Med Chem; 2005 May; 40(5):467-72. PubMed ID: 15893020
[TBL] [Abstract][Full Text] [Related]
57. Surfactant-cobalt(III) complexes: synthesis, critical micelle concentration (CMC) determination, DNA binding, antimicrobial and cytotoxicity studies.
Kumar RS; Arunachalam S; Periasamy VS; Preethy CP; Riyasdeen A; Akbarsha MA
J Inorg Biochem; 2009 Jan; 103(1):117-27. PubMed ID: 18986707
[TBL] [Abstract][Full Text] [Related]
58. Cytotoxicity of half sandwich ruthenium(II) complexes with strong hydrogen bond acceptor ligands and their mechanism of action.
Das S; Sinha S; Britto R; Somasundaram K; Samuelson AG
J Inorg Biochem; 2010 Feb; 104(2):93-104. PubMed ID: 19913918
[TBL] [Abstract][Full Text] [Related]
59. In vitro study of the cytotoxicities of two mixed-ligand oxovanadium complexes on human hepatoma cells.
Zhang YL; Wang XS; Fang W; Cai XY; Li HZ; Mao JW; Jin XB; Bai YL; Lu JZ
Pharmazie; 2013 Oct; 68(10):827-34. PubMed ID: 24273888
[TBL] [Abstract][Full Text] [Related]
60. Synthesis, crystal structures, and anti-convulsant activities of ternary [Zn(II)(3,5-diisopropylsalicylate)(2)], [Zn(II)(salicylate)(2)] and [Zn(II)(aspirinate)(2)] complexes.
Lemoine P; Viossat B; Dung NH; Tomas A; Morgant G; Greenaway FT; Sorenson JR
J Inorg Biochem; 2004 Nov; 98(11):1734-49. PubMed ID: 15522401
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
